von Tobias Borgers | Jan 25, 2022 | Boehringer
Boehringer Ingelheim advances to one of eleven global top employers worldwideThis is the second consecutive year for the global certification, and the second consecutive year for the certification in Australia & New ZealandHigh scores in values, ethics and...
von Tobias Borgers | Jan 18, 2022 | Allgemein, Boehringer
Medikamente: Schnellere Einführung durch Digital-Produktion Ingelheim (dpa/lrs) – Kurze Wege von der Forschung bis zum neuen Medikament in der Apotheke – dies soll eine neue Tablettenfabrik des Pharma-Unternehmens Boehringer Ingelheim ermöglichen, die am...
von Tobias Borgers | Jan 11, 2022 | Bayer
Berlin, Deutschland/Brisbane, Kalifornien, USA, 10. Januar 2022 – Die Bayer AG geht mit Mammoth Biosciences, Inc. eine strategische Partnerschaft bei der Entwicklung von CRISPR Produkten der nächsten Generation ein. Die Partnerschaft, die zusätzlich mit einer...
von Tobias Borgers | Jan 4, 2022 | Glaxo
EMERYVILLE, Calif.–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today the expansion of an existing collaboration and license agreement between its subsidiary, Icagen, and GlaxoSmithKline (GSK). The expansion will leverage...
von Tobias Borgers | Jan 4, 2022 | Glaxo
September 13, 2021 | When Mike Montello joined the GSK team, the first steps of the pharma’s digital transformation had already taken place. His focus was to integrate the enterprise digital transformation to support another transformation taking place in R&D. “We...
von Tobias Borgers | Dez 14, 2021 | Boehringer
Boehringer Ingelheim India has shared its roadmap of partnerships and patient access programmes to sustain its growth momentum in 2021. Vani Manja, Managing Director, Boehringer Ingelheim India said, “Boehringer Ingelheim India aspires to be amongst the top five...
